A groundbreaking ultrafast sequencing technology promises to revolutionize brain tumor diagnosis, enabling surgeons to classify tumors within two hours during surgery, potentially altering treatment strategies and improving patient outcomes.
A groundbreaking ultrafast sequencing technology promises to revolutionize brain tumor diagnosis, enabling surgeons to classify tumors within two hours during surgery, potentially altering treatment strategies and improving patient outcomes.